Navigation Links
'Ancestral eve' was mother of all tooth decay

A New York University College of Dentistry (NYUCD) research team has found the first oral bacterial evidence supporting the dispersal of modern Homo sapiens out of Africa to Asia.

The team, led by Page Caufield, a professor of cariology and comprehensive care at NYUCD, discovered that Streptoccocus mutans, a bacterium associated with dental caries, has evolved along with its human hosts in a clear line that can be traced back to a single common ancestor who lived in Africa between 100,000 and 200,000 years ago.

S. mutans is transmitted from mothers to infants, and first appears in an infant’s mouth at about two years of age. Caufield’s findings are reported in an article in the February issue of the Journal of Bacteriology.

In his analysis of the bacterium, Caufield used DNA fingerprints and other biomarkers that scientists have also employed to trace human evolution back to a single common African ancestor, known as "ancestral Eve."

"As humans migrated around the world and evolved into the different races and ethnicities we know today," Caufield said, "this oral bacterium evolved with them in a simultaneous process called coevolution."

"It is relatively easy to trace the evolution of S. mutans, since it reproduces through simple cell division," says Caufield, who gathered over 600 samples of the bacterium on six continents over the past two decades. His final analysis focused on over 60 strains of S. mutans collected from Chinese and Japanese; Africans; African-Americans and Hispanics in the United States; Caucasians in the United States, Sweden, and Australia; and Amazon Indians in Brazil and Guyana.

"By tracing the DNA lineages of these strains," Caufield said, "We have constructed an evolutionary family tree with its roots in Africa and its main branch extending to Asia. A second branch, extending from Asia back to Europe, traces the migration of a small group of Asians who founded at least
'"/>

Source:New York University


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
3. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
4. Report that delayed motherhood decreases life expectancy of mouse offspring
5. Tendency to hair loss inherited from the mother
6. USC researchers determine mechanism of action of chemotherapy drug
7. Studies clarify risk factors for mother-to-child transmission of hepatitis C virus
8. Mining biotechs data mother lode
9. Gene expression profile helps predict chemotherapy response in ovarian cancer patients
10. Ultrasounds show mothers drinking shrinks fetal brain
11. Hyena mothers give their cubs a helpful dose of hormones
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ancestral eve was mother all tooth decay

(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
(Date:4/2/2015)... BETHESDA, Md. , April 2, 2015 ... Salt Lake City , the American ... election of five new directors to its Board.  Members ... for the ACMG and for forming and advancing its ... the medical genetics profession. "It,s an eventful ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... meaning and are made with the expectation of specific ... from the University of St. Andrews in the UK. ... significant step forward with the authors, new systematic approach ... non-humans, applied here to a group of orangutan gestures. ...
... burgeon in the atmosphere causing the Earth,s climate to warm, ... gas from the atmosphere and store it where it can ... of Iceland has been studying the possibility of sequestration of ... findings today to several thousand geochemists from around the world ...
... the College of Engineering at the University of Miami ... 25 years to enhancing IEEE,s image and improving the ... being honored with the 2010 IEEE Richard M. Emberson ... technology for humanity. , "I am deeply honored by ...
Cached Biology News:Signal like you mean it 2Storing carbon dioxide deep underground in rock form 2Dean of the UM College of Engineering to receive 2010 IEEE Richard M. Emberson Award 2Dean of the UM College of Engineering to receive 2010 IEEE Richard M. Emberson Award 3
(Date:4/29/2015)... ON , April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... periods ended December 31, 2014. Biorem,s complete fiscal 2014 year-end financial statements ... FINANCIAL HIGHLIGHTS: 2014 , 2013 , 2014 ... 10,683 , 19,596 Gross profit 1,326 , 1,703 ... 1,191 , 1,493 , 3,377 , ...
(Date:4/29/2015)... -- Cambrex Corporation (NYSE: CBM ) announced that first ... 1, 2015 before the market opens. , ... conference call to discuss the financial results. First Quarter 2015 ... Friday, May 1, 2015 at 8:30 a.m. Eastern Time ... International  Passcode:  7993632 Dial-in Replay: , ...
(Date:4/29/2015)... Poway, CA (PRWEB) April 29, 2015 ... proud to announce that its regenerative stem cell therapy ... founded in 2002, seeking to discover a successful treatment ... ligaments. , In 2003 VetStem signed a worldwide exclusive ... veterinary application, and the first horse was treated in ...
(Date:4/29/2015)... , April 29, 2015 /CNW/ - Northern Biologics Inc., ... Ventures, today announced an exclusive, strategic collaboration with ... Biologics received a US$30 million upfront cash payment. ... develop first-in-class therapeutic antibodies, and will have the ... the advancement of its portfolio. ...
Breaking Biology Technology:Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2Northern Biologics and Celgene Enter Strategic Collaboration 2
... Evaluable Patients Had Confirmed Partial Responses (25%); ... Antonio Breast Cancer Symposium, HAYWARD, Calif., Dec. ... today announced that its Hsp90 inhibitor,tanespimycin, demonstrated meaningful ... in patients with HER2-positive metastatic breast cancer,when administered ...
... Global Biotechnology Company Adopts Pharsight,s Groundbreaking ... Automation Software, ... ), a leading provider of software and strategic,services for optimizing clinical ... purchased WinNonlin AutoPilot.,This sale marks Pharsight,s third new customer win since ...
... New Deal Provides a Further Opportunity for OGeS ... Sciences (UK) Ltd "OGeS" announces today that it ... discover, develop and,commercialise novel therapeutic antibodies for the ... to further strengthen its pipeline,of fully human therapeutic ...
Cached Biology Technology:Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 2Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 3Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 4Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 5Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer 2Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer 3Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 2Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 3
... SYBR Green I nucleic acid gel stain ... that has bright fluorescence when bound to dsDNA ... for detecting dsDNA in gels using laser scanners ... acid stain has also found uses in capillary ...
... acid gel stain has bright fluorescence when bound ... it ideal for detecting dsDNA in gels using ... Green I nucleic gel acid stain has ... assays and bandshift assays. One mL stains 100 ...
... In 1959, McCoy and his ... requirements for in vitro cultivation ... studies were performed using,Basal Medium ... create a new medium known ...
... advanced protein cross-linking techniques are defined by ... Shan S. Wong. This valuable hardcover guide ... and current application references. More than 300 ... cross-linking and conjugate preparation from selection ...
Biology Products: